Company Overview and News

0
Clairvest Reports Fiscal 2018 Fourth Quarter and Year-End Results

2018-06-27 globenewswire
TORONTO, June 27, 2018 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX:CVG) today reported results for the fourth quarter and year ended March 31, 2018 and material events which occurred subsequent to year-end. (All figures are in Canadian dollars unless otherwise stated)
GCGMF GC CVG CVTGF

26
Great Canadian Gaming: Public Documents Prove Why Successful Capital Allocators Invested In Ontario

2018-06-25 seekingalpha
We expect its share price to ~double over the next four years and think downside is limited given the recent unwarranted selloff.
GCGMF BAMGF GC CZR BBU CVG CVTGF BAMKF BAM

32
CANADA STOCKS-TSX dips as falling oil prices weigh on energy stocks

2018-06-21 reuters
June 21 (Reuters) - Canada’s main stock index dipped on Thursday after lower oil prices dragged down shares of energy companies.
ASGTF ENBBF PXT PARXF ACBFF ENB CGC GCGMF ENB GC TWMJF ACB AIF CNQ WEED EBBNF

31
CANADA STOCKS - TSX rises 0.64 pct, helped by energy

2018-06-20 reuters
NEW YORK, June 20 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 104.42 points, or 0.64 percent, to 16,420.95. * The biggest contributor to the TSX gain was Toronto Dominion Bank, while the energy sector provided the biggest boost. * Leading the index were Canopy Growth Corp, up 6.7 percent, MEG Energy Corp, up 6.4 percent, and Bombardier Inc, up by 5.5 percent. * Lagging shares were Great Canadian Gaming Corp, down 10.
GOOS ACBFF MEG TCLAF TCLCF CGC TD GCGMF GC TWMJF ACB WEED BDRPF MEGEF

9
Great Canadian Gaming: Are Shareholders About To Roll Snake-Eyes?

2018-06-20 seekingalpha
Offers potential downside of -40% to -64% from its current price of $55.54/shr. Stock has rallied +135% LTM on the back of a key contract win.
GCGMF GC CZR BBU CVG PENN CVTGF

23
Clairvest - Buying Quality Private Equity Assets At A Discount

2018-06-19 seekingalpha
Bargain purchase of large casino asset from motivated seller will be realized on the next balance sheet.
GCGMF BAMGF GC BBU CVTGF BAMKF BAM

12
CANADA STOCKS - TSX rises 0.15 percent for seventh straight gain

2018-05-11 reuters
NEW YORK, May 11 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 23.82 points, or 0.15 percent, to 15,983.32, its seventh straight gain. The index rose 1.6 for the week, its best weekly performance since mid-February. * The biggest contributor to the TSX gain was Enbridge with 10.9 net index points. Energy was the top sector contributor with 16.1 net points. * Leading the index were Great Canadian Gaming Corp, up 7.
GCGMF ENB GC ENBBF SSRM MEG MEGEF TSG EBBNF ENB TXG TORXF

26
CANADA STOCKS - TSX rises 0.31 percent, lifted by Enbridge

2018-05-10 reuters
NEW YORK, May 10 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 48.69 points, or 0.31 percent, to 15,959.50. * The biggest contributor to the TSX gain was Enbridge, up 1.9 percent, to add 9.45 net index points after the pipeline company posted quarterly results and said it may sell more assets this year. Materials was the top sector contributor with a 15 net points boost.
ENBBF OTEX PAAS ENB GCGMF ENB GC OTC CNQ TSG EBBNF BTE CADNF POU PRMRF

11
CANADA STOCKS-TSX climbs on gold miners, Enbridge Inc

2018-05-10 reuters
TORONTO, May 10 (Reuters) - Canada’s main index climbed higher on Thursday, as gold miners gained along higher with prices for the precious metal, and Enbridge Inc was boosted by strong results.
ENBBF TMXXF OTEX TXCX ENB GCGMF ENB GC X OTC MGA MG EBBNF ATHOF ATH TU

0
StorageVault Announces Jay Lynne Fleming as Nominee for Director

2018-05-01 globenewswire
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- STORAGEVAULT CANADA INC. (“StorageVault” or the “Corporation”) (TSX-V:SVI) is pleased to announce that Jay Lynne Fleming will be a nominee for election as a director of StorageVault at the Annual General and Special Meeting of Shareholders (the “Meeting”) to be held on Wednesday, May 30, 2018 at 2:00 p.m. at Suite 6000, 1 First Canadian Place, 100 King Street W, Toronto, ON.
GCGMF GC SVI

0
City council bets big on gambling expansion at Woodbine Racetrack

2018-04-27 cbc.ca
Toronto council gave its final approval on Thursday to a community benefits agreement between the city and a consortium charged with expanding gambling operations at the Woodbine Racetrack.
GCGMF GC

0
Rexdale residents want childcare in Woodbine casino plans

2018-04-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
GCGMF GC

4
Woodbine Racetrack promises to hire locally and pay Toronto $31 million a year for casino expansion

2018-04-13 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
GCGMF GC BBU

0
Ajax to fight for casino awarded to Pickering

2018-04-06 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
GCGMF GC

4
Pickering to open casino in late 2019

2018-04-04 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
GCGMF GC BBU

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 389914102